Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-14-000423
Filing Date
2014-02-06
Accepted
2014-02-06 16:13:57
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1414353.html 3  
1 OWNERSHIP DOCUMENT zk1414353.xml 3 3137
  Complete submission text file 0001178913-14-000423.txt   4770
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address
Gur-Lavie Boaz (Reporting) CIK: 0001596407 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31392 | Film No.: 14580312